Anti-androgen treatment of prostatic carcinoma may be a risk factor for development of rheumatoid arthritis

J Rheumatol. 2002 Nov;29(11):2459-62.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Androgen Antagonists / adverse effects*
  • Arthritis, Rheumatoid / chemically induced*
  • Humans
  • Male
  • Middle Aged
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / drug therapy*
  • Risk Factors
  • Testosterone / blood

Substances

  • Androgen Antagonists
  • Testosterone
  • Prostate-Specific Antigen